AbbVie is a global biopharmaceutical company based in North Chicago, Illinois, founded in 2013 as a spin-off from Abbott Laboratories. The company focuses on discovering, developing, and delivering innovative medicines in key therapeutic areas such as immunology, neuroscience, oncology, eye care, virology, gastroenterology, and womens health. AbbVie expanded its portfolio through the acquisition of Allergan, which added aesthetics and related products.

AbbVie is known for its flagship product, Humira, a widely used treatment for autoimmune diseases. The company has a strong pipeline of medicines, including Viekira Pak for hepatitis C, Duopa for Parkinsons disease, and therapies for cancer like Imbruvica and Venclexta. With over $50 billion invested in research and development since its inception, AbbVie aims to create advanced pharmaceutical treatments for complex health conditions. The company serves a diverse customer base, reaching more than 30 million people globally and operating in over 70 countries with a workforce of more than 50,000 employees. AbbVie is committed to patient-centered innovation and improving health outcomes worldwide.